Jinhe Biotechnology CO., LTD.

SZSE:002688 주식 보고서

시가총액: CN¥3.3b

Jinhe Biotechnology 과거 수익 실적

과거 기준 확인 4/6

Jinhe Biotechnology's earnings have been declining at an average annual rate of -19.3%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 5% per year. Jinhe Biotechnology's return on equity is 3.7%, and it has net margins of 4.3%.

주요 정보

-19.3%

수익 성장률

-25.2%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률5.0%
자기자본 수익률3.7%
순이익4.3%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

May 27
Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

May 13
Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13
Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

수익 및 비용 분석

Jinhe Biotechnology 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

SZSE:002688 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 242,2629738085
30 Jun 242,2078838280
31 Mar 242,1669537978
31 Dec 232,1748637474
30 Sep 232,0607639172
30 Jun 232,0307837675
31 Mar 232,1308136378
01 Jan 232,1237635482
30 Sep 222,2728632978
30 Jun 222,2427832876
31 Mar 222,1365631574
01 Jan 222,0789431872
30 Sep 212,04612631670
30 Jun 211,92712531069
31 Mar 211,84413331869
31 Dec 201,81511730966
30 Sep 201,74114430963
30 Jun 201,79717530162
31 Mar 201,83120130356
31 Dec 191,78218530561
30 Sep 191,76717832760
30 Jun 191,75918333951
31 Mar 191,67617133150
31 Dec 181,62916431641
30 Sep 181,60313831937
30 Jun 181,52111727354
31 Mar 181,4579827543
31 Dec 171,45810827534
30 Sep 171,41414024221
30 Jun 171,4401472720
31 Mar 171,4861552660
31 Dec 161,4961642550
30 Sep 161,4501592370
30 Jun 161,3961482230
31 Mar 161,3151322010
31 Dec 151,2501051920
30 Sep 151,143841820
30 Jun 151,030791540
31 Mar 15956801440
31 Dec 14840771420
30 Sep 14771871410
30 Jun 14765951330
31 Mar 14756931320
31 Dec 13741901260

양질의 수익: 002688 has high quality earnings.

이익 마진 증가: 002688's current net profit margins (4.3%) are higher than last year (3.7%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 002688's earnings have declined by 19.3% per year over the past 5 years.

성장 가속화: 002688's earnings growth over the past year (27.5%) exceeds its 5-year average (-19.3% per year).

수익 대 산업: 002688 earnings growth over the past year (27.5%) exceeded the Pharmaceuticals industry -1.2%.

자기자본 수익률

높은 ROE: 002688's Return on Equity (3.7%) is considered low.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y